Avalo Therapeutics, Inc. (AVTX) EV to EBITDA (2017 - 2018)
Avalo Therapeutics' (AVTX) EV to EBITDA was 13.47 for Q2 2018, up 37.2% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics, Inc. (AVTX) EV to EBITDA (2017 - 2018) Analysis & Trends
Over the twelve months ended Jun 30, 2018, Avalo Therapeutics' EV to EBITDA came in at 10.76; for FY2017, it came in at 10.23.
- Per Business Quant data, the three quarters before Q2 2018 came in at 9.82 (Q1 2018), 10.23 (Q4 2017) and 1.48 (Q3 2017).
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 13.47 |
| Mar 31, 2018 | 9.82 |
| Dec 31, 2017 | 10.23 |
| Sep 30, 2017 | 1.48 |
API Access
Avalo Therapeutics, Inc. EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();